Navigation Links
Walther Cancer Foundation grant funds new IU Simon Cancer Center Web site section
Date:3/3/2009

INDIANAPOLIS -- For some cancer patients, the soles of their feet and the palms of their hands burn or tingle, while others may become forgetful because of some types of chemotherapy. Patients' family members also can feel anxious and concerned about their loved one's well-being.

Both share a need for quick answers or more detailed information about a broad range of topics involving diagnosis, treatments, or unexpected symptoms.

A new section of the Indiana University Melvin and Bren Simon Cancer Center's web site, www.cancerinfo.cancer.iu.edu, helps patients and their families find information about a variety of topics in an easily accessible format.

In the symptom management section, for example, people can learn about anemia, dry mouth, nausea, and shortness of breath.

Overall, according to Anna McDaniel, DNS, a professor at the IU School of Nursing and a researcher with the IU Simon Cancer Center, the section "makes information more accessible to the public as well as patients. It has been designed so there is a clearly defined way to access quality, or evidence based, information."

Such information is beneficial for patients. "Research has shown that having access to good information can increase coping in cancer patients and lead to better treatment outcomes," Dr. McDaniel said.

Dr. McDaniel received a $250,000 grant from Indianapolis-based Walther Cancer Foundation in 2007 for the project. She and others from the IU schools of nursing and informatics and the cancer center worked together to create the section, which made its debut Feb. 23.

The new section is dedicated to Dr. Harold Burdette, a visionary leader committed to eliminating the burden of cancer in Indiana.

Dr. McDaniel and others are now testing the section's next phase, which takes symptom management to an interactive level.

Patients will log into a secure system to answer questions about any side effects they might be experiencing from chemotherapy. They will rate their symptoms on a scale of zero to 10. Depending on the severity of the symptoms, the patient will be directed to information on the Internet, or his or her oncologist will be notified.

Twenty patients are currently being recruited into this test phase.

"The unique aspect of this is that it will connect the patient and the health-care provider," Dr. McDaniel said. "Not only does the system give patients useful information about how to help themselves during chemotherapy, it increases communication with oncology doctors and nurses."


'/>"/>

Contact: Michael Schug
maschug@iupui.edu
317-278-0953
Indiana University
Source:Eurekalert

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: